Entekor 0.5mg Tablet

Entekor 0.5mg Tablet

Prescription requiredRx Required

Salt Composition: Entecavir

Expiry Date: 01/2028

Special offer

Buy at $50.59

$50.59

Inclusive of all taxes

▼

30 Tablet

About The Product

​Hepatitis B, Liver infection​

Description

Entekor 0.5mg Tablet is an antiviral medication used to treat Chronic Hepatitis B Virus Infection in the body. Entekor 0.5mg Tablet is an antiviral medicine that contains 1mg of Entecavir chemical based salt.

Entecavir is a nucleoside analogue that, after activation within infected liver cells, selectively inhibits hepatitis B viral DNA polymerase, thereby blocking viral DNA synthesis. It primarily suppresses viral replication and reduces viral load, which in turn helps minimize liver inflammation and slow disease progression.

While entecavir effectively controls hepatitis B, it does not reliably eradicate the virus; long-term treatment is typically required, and complete viral clearance is rare.

Uses

  • Hepatitis B Infection

Common Side Effects

Entekor 0.5mg Tablet is an antiviral medicine that  contains Entacevir chemical based salt. like any other chemical based medicine. It also has ranges of side effects from mild to extreme. Consult your doctor if symptoms persist for longer period of time.

  • Nausea
  • Diarrhea
  • Headache
  • Mood changes (irritability, depression)
  • Reduced appetite
  • Insomnia
  • Fatigue
  • Severe allergic reactions
  • Slow heart rate (bradycardia)

Dosage And Administration

  • Entekor 0.5mg Tablet is an orally administered medicine. It is supposed to be swollen with water as it is on an empty stomach at least 2 hours before and 2 hours after food, at the same time every day.
  • Avoid breaking, biting and chewing of tablet as it may affect the medicine efficacy. The dosage depends on the infection stage and pateints'overall health. Consult your doctor for your exact dosage and its timing.

Mechanism Of Action

  • Entekor 0.5mg Tablet contains Entecavir salt that attacks the viral replication machinery in the host's body. Entecavir stops viral replication mainly by being converted inside infected cells into an active form that directly inhibits the viral RNA polymerase enzyme, preventing the virus from copying its genetic material correctly.
  • Entecavir also increases mutations in viral RNA, causing the production of defective viruses, and modulates the immune response to enhance antiviral activity. As a result, it reduces viral load in the body, reduces viral inflammation, controls virus progression as well as ultimately eradicating virus traces in the body.

Safety Advice

Alcohol

It is generally recommended to avoid or limit alcohol consumption while patient is on Entekor 0.5mg Tablet medication course. Consult your doctor for personalized guidance.

Driving

Entekor 0.5mg Tablet consumption lead to side effects such as dizziness, headache, nausea etc that can affect the patient's ability to drive. Therefore, it is not recommended to drive after consuming this medication. Consult your doctor for more information.

Pregnancy

Entekor 0.5mg Tablet consumption is not allowed during pregnancy period as it can cause harm to growing baby in womb. Talk to your doctor about the same.

Breast Feeding

Breastfeeding should also be discontinued while mother is on Entekor 0.5mg Tablet medication course. To know more, seek personal guidance from your doctor.

Kidney

Share your medical history details related to kidney cancer or any other disease with your doctor before taking Entekor 0.5mg Tablet.

Liver

Notify your doctor about any liver disease or infection before starting Entekor 0.5mg Tablet course. As it can cause serious liver damage.

Faqs

Entekor 0.5mg Tablet is an antiviral medication used to treat Chronic Hepatitis B Virus Infection in the body.

References

  • Ceylan, B., Yardimci, C., Fincanci, M., Eren, G., Tozalgan, U., Muderrisoglu, C., & Akkoyunlu, Y. A. S. E. M. İ. N. (2013). Comparison of tenofovir and entecavir in patients with chronic HBV infection. https://pubmed.ncbi.nlm.nih.gov/24089225/
  • Matthews, S. J. (2006). Entecavir for the treatment of chronic hepatitis B virus infection. Clinical therapeutics, 28(2), 184-203. https://pubmed.ncbi.nlm.nih.gov/16678641/
  • Shaw, T., & Locarnini, S. (2004). Entecavir for the treatment of chronic hepatitis B. Expert review of anti-infective therapy, 2(6), 853-871. https://pubmed.ncbi.nlm.nih.gov/15566330/
  • Robinson, D. M., Scott, L. J., & Plosker, G. L. (2006). Entecavir: a review of its use in chronic hepatitis B. Drugs, 66(12), 1605-1622. https://pubmed.ncbi.nlm.nih.gov/19496629/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026